Header Logo

Connection

FILIP JANKU to Active Transport, Cell Nucleus

Back to Details
This is a "connection" page, showing publications FILIP JANKU has written about Active Transport, Cell Nucleus.
FILIP JANKU
Connection Strength
0.046
Active Transport, Cell Nucleus
  1. Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs. 2021 10; 39(5):1357-1365.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.